|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01873 VIVA BIOTECH
Nominal 
2.010 +0.160 (+8.649%) Non-current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Investment Properties | -- | -- | 0 | 115,500 | 0 | 0 |
| Property, plant, equip. & others | -- | -- | 1,304,455 | 1,350,917 | 1,501,711 | 1,269,870 |
| Land & other Lease Assets | -- | -- | 292,863 | 303,614 | 435,669 | 454,031 |
| Intangible Assets | -- | -- | 2,522,468 | 2,577,088 | 2,632,480 | 2,687,863 |
| Interests in Asso. & JCEs | -- | -- | 46,808 | 42,403 | 0 | 0 |
| Other Non-current Assets | -- | -- | 1,007,402 | 1,029,472 | 1,412,188 | 1,649,209 |
| -- | -- | 5,173,996 | 5,418,994 | 5,982,048 | 6,060,973 | |
Current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Inventories | -- | -- | 272,700 | 259,707 | 326,031 | 231,721 | |
| Trade Receivables | -- | -- | 420,464 | 407,405 | 445,969 | 429,703 | |
| Cash & Bank Balances | -- | -- | 941,581 | 1,036,322 | 678,569 | 800,947 | |
| Other Current Assets | -- | -- | 119,924 | 327,484 | 488,238 | 521,414 | |
| Assets Held for Sale | -- | -- | 121,929 | 0 | 0 | 0 | |
| -- | -- | 1,876,598 | 2,030,918 | 1,938,807 | 1,983,785 | ||
Current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |||
| Trade Payables | -- | -- | 309,355 | 245,756 | 326,130 | 281,053 | ||
| S-T Debt & Leases | -- | -- | 552,484 | 952,441 | 1,916,180 | 238,744 | ||
| Other Current Liabilities | -- | -- | 264,762 | 335,981 | 430,247 | 406,806 | ||
| Liab asso w/ Assets Held for Sale | -- | -- | 54 | 0 | 0 | 0 | ||
| -- | -- | 1,126,655 | 1,534,178 | 2,672,557 | 926,603 | |||
| Net Current Assets | -- | -- | 749,943 | 496,740 | (733,750) | 1,057,182 | ||
| Total Assets Less Current Liabilities | -- | -- | 5,923,939 | 5,915,734 | 5,248,298 | 7,118,155 | ||
Non-current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||||
| L-T Debt & Leases | -- | -- | 731,567 | 950,776 | 906,760 | 2,415,953 | |||
| Other Non-current Liabilities | -- | -- | 1,376,151 | 1,277,046 | 736,824 | 788,846 | |||
| -- | -- | 2,107,718 | 2,227,822 | 1,643,584 | 3,204,799 | ||||
Capital and Reserves
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |||||
| Share Capital | -- | -- | 367 | 367 | 326 | 326 | ||||
| Reserves | -- | -- | 3,802,010 | 3,687,545 | 3,178,190 | 3,444,299 | ||||
| Others | -- | -- | 0 | 0 | 426,198 | 468,731 | ||||
| Shareholders' Funds | -- | -- | 3,802,377 | 3,687,912 | 3,604,714 | 3,913,356 | ||||
| Non-controlling Interests | -- | -- | 13,844 | 0 | 0 | 0 | ||||
| Others | -- | -- | 0 | 0 | 0 | 0 | ||||
| -- | -- | 3,816,221 | 3,687,912 | 3,604,714 | 3,913,356 | |||||
Commitments and Contingent Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Commitments | -- | -- | 84,618 | 166,333 | 326,732 | 491,174 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 01/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 219,761 |
| %Change | 31.362% |
| EPS / (LPS) | RMB 0.100 |
| NBV Per Share (¥) | RMB -- |